182 related articles for article (PubMed ID: 26110817)
21. Pandemic pharmaceutical dosing effects on wastewater treatment: no adaptation of activated sludge bacteria to degrade the antiviral drug oseltamivir (Tamiflu®) and loss of nutrient removal performance.
Slater FR; Singer AC; Turner S; Barr JJ; Bond PL
FEMS Microbiol Lett; 2011 Feb; 315(1):17-22. PubMed ID: 21133989
[TBL] [Abstract][Full Text] [Related]
22. The presence of acidic and neutral drugs in treated sewage effluents and receiving waters in the Cornwallis and Annapolis River watersheds and the Mill CoveSewage Treatment Plant in Nova Scotia, Canada.
Crouse BA; Ghoshdastidar AJ; Tong AZ
Environ Res; 2012 Jan; 112():92-9. PubMed ID: 22178020
[TBL] [Abstract][Full Text] [Related]
23. Antiviral pandemic risk assessment for urban receiving waters.
Ellis JB
Water Sci Technol; 2010; 61(4):879-84. PubMed ID: 20182065
[TBL] [Abstract][Full Text] [Related]
24. Distribution and pollutant load of hexabromocyclododecane (HBCD) in sewage treatment plants and water from Japanese Rivers.
Ichihara M; Yamamoto A; Takakura K; Kakutani N; Sudo M
Chemosphere; 2014 Sep; 110():78-84. PubMed ID: 24880602
[TBL] [Abstract][Full Text] [Related]
25. The occurrence of antihistamines in sewage waters and in recipient rivers.
Kosonen J; Kronberg L
Environ Sci Pollut Res Int; 2009 Jul; 16(5):555-64. PubMed ID: 19337767
[TBL] [Abstract][Full Text] [Related]
26. Contributions of genotoxic precursors from tributary rivers and sewage effluents to the Yodo River in Japan.
Nobukawa T; Sanukida S
Water Res; 2002 Feb; 36(4):989-95. PubMed ID: 11848371
[TBL] [Abstract][Full Text] [Related]
27. Drugs of abuse and their metabolites in the Ebro River basin: occurrence in sewage and surface water, sewage treatment plants removal efficiency, and collective drug usage estimation.
Postigo C; López de Alda MJ; Barceló D
Environ Int; 2010 Jan; 36(1):75-84. PubMed ID: 19913915
[TBL] [Abstract][Full Text] [Related]
28. Clinical efficacy of laninamivir and peramivir in patients with seasonal influenza: a randomized clinical trial.
Yoshino Y; Seo K; Koga I; Kitazawa T; Ota Y
Infect Dis (Lond); 2017 May; 49(5):417-419. PubMed ID: 27766921
[No Abstract] [Full Text] [Related]
29. Predicting concentrations of the cytostatic drugs cyclophosphamide, carboplatin, 5-fluorouracil, and capecitabine throughout the sewage effluents and surface waters of Europe.
Johnson AC; Oldenkamp R; Dumont E; Sumpter JP
Environ Toxicol Chem; 2013 Sep; 32(9):1954-61. PubMed ID: 23893496
[TBL] [Abstract][Full Text] [Related]
30. Spatial distribution and importance of potential perfluoroalkyl acid precursors in urban rivers and sewage treatment plant effluent--case study of Tama River, Japan.
Ye F; Tokumura M; Islam MS; Zushi Y; Oh J; Masunaga S
Water Res; 2014 Dec; 67():77-85. PubMed ID: 25262552
[TBL] [Abstract][Full Text] [Related]
31. Estrogenicity of solid phase-extracted water samples from two municipal sewage treatment plant effluents and river Rhine water using the yeast estrogen screen.
Pawlowski S; Ternes TA; Bonerz M; Rastall AC; Erdinger L; Braunbeck T
Toxicol In Vitro; 2004 Feb; 18(1):129-38. PubMed ID: 14630071
[TBL] [Abstract][Full Text] [Related]
32. Determination of a N-Nitrosodimethylamine Precursor in Water Using Ultra-high Performance Liquid Chromatography-Tandem Mass Spectrometry.
Kosaka K; Asami M; Ohkubo K; Akiba M
Anal Sci; 2015; 31(8):769-72. PubMed ID: 26256599
[TBL] [Abstract][Full Text] [Related]
33. Identification of a new N-nitrosodimethylamine precursor in sewage containing industrial effluents.
Kosaka K; Asami M; Ohkubo K; Iwamoto T; Tanaka Y; Koshino H; Echigo S; Akiba M
Environ Sci Technol; 2014 Oct; 48(19):11243-50. PubMed ID: 25184404
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro.
Gubareva LV; Trujillo AA; Okomo-Adhiambo M; Mishin VP; Deyde VM; Sleeman K; Nguyen HT; Sheu TG; Garten RJ; Shaw MW; Fry AM; Klimov AI
Antivir Ther; 2010; 15(8):1151-9. PubMed ID: 21149922
[TBL] [Abstract][Full Text] [Related]
35. Potential risks associated with the proposed widespread use of Tamiflu.
Singer AC; Nunn MA; Gould EA; Johnson AC
Environ Health Perspect; 2007 Jan; 115(1):102-6. PubMed ID: 17366827
[TBL] [Abstract][Full Text] [Related]
36. Environmental fate of the antiviral drug Tamiflu in two aquatic ecosystems.
Saccà ML; Accinelli C; Fick J; Lindberg R; Olsen B
Chemosphere; 2009 Mar; 75(1):28-33. PubMed ID: 19124147
[TBL] [Abstract][Full Text] [Related]
37. [Current anti-influenza virus chemotherapy].
Yoshioka D; Tokimatsu I; Ishii H; Kadota J
Nihon Rinsho; 2010 Sep; 68(9):1679-84. PubMed ID: 20845747
[TBL] [Abstract][Full Text] [Related]
38. Occurrence of antibiotics and antibiotic resistance genes in a sewage treatment plant and its effluent-receiving river.
Xu J; Xu Y; Wang H; Guo C; Qiu H; He Y; Zhang Y; Li X; Meng W
Chemosphere; 2015 Jan; 119():1379-1385. PubMed ID: 24630248
[TBL] [Abstract][Full Text] [Related]
39. Incidence of anticancer drugs in an aquatic urban system: from hospital effluents through urban wastewater to natural environment.
Ferrando-Climent L; Rodriguez-Mozaz S; Barceló D
Environ Pollut; 2014 Oct; 193():216-223. PubMed ID: 25062279
[TBL] [Abstract][Full Text] [Related]
40. The environmental fate of the antiviral drug oseltamivir carboxylate in different waters.
Bartels P; von Tümpling W
Sci Total Environ; 2008 Nov; 405(1-3):215-25. PubMed ID: 18675443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
